Skip to main content
. 2011 Oct 27;33(7):921–926. doi: 10.1093/eurheartj/ehr392

Table 2.

Patient characteristics and reperfusion therapy in patients with pulmonary embolism

Total (n =644) Age ≥65 (n =389) Age <65 (n= 255) P-value
Dyspnoea, n (%) 527 (82.5) 331 (85.5) 196 (77.8) 0.012
Positive (N-terminal pro) BNP,an (%) 150/249 (60.2) 121/180 (67.2)  29/69 (42.0) <0.001
Right heart strain by ECG,bn (%) 233/499 (46.7) 149/305 (48.9)  84/194 (43.3) 0.23
Concomitant DVT, n (%) 227 (35.3) 126 (32.4) 101 (39.6) 0.06
Oxygen saturation in room air <90%, n (%) 174/577 (30.2) 124/340 (36.5)  50/237 (21.1) <0.001
Positive troponin T or I,an (%)  99/387 (25.6)  79/251 (31.5)  20/136 (14.7) <0.001
Heart rate ≥110 b.p.m., n (%) 158/619 (25.5) 100/369 (27.1)  58/250 (23.2) 0.28
Syncope, n (%)  64 (10.0)  44 (11.3)  20 (7.9) 0.16
Massive PE,cn (%)  39 (6.1)  29 (7.5)  10 (3.9) 0.07
High sPESI,dn (%) 430 (66.8) 304 (78.2) 126 (49.4) <0.001

Reperfusion therapy, n (%)  36 (5.6)  20 (5.1)  16 (6.3) 0.54
 Systemic thrombolysis, n (%)  21 (3.3)  13 (3.3)   8 (3.1) 0.89
 Catheter intervention, n (%)  10 (1.6)   5 (1.3)   5 (2.0) 0.50
 Surgical thrombectomy, n (%)   9 (1.4)   3 (0.8)   6 (2.4) 0.09

aA positive biomarker test result was defined as a quantitative biomarker level above the manufacturer's assay threshold.

bRight heart strain by electrocardiography (ECG) was defined as the presence of at least one of the following signs: sinus tachycardia, incomplete or complete right bundle branch block, SI-QIII type, or negative T-waves in V2, V3, or V4 within 24 h of VTE diagnosis.

cMassive PE was defined as PE with systolic arterial hypotension (systolic blood pressure of <90 mmHg) or as PE requiring cardiopulmonary resuscitation or the administration of catecholamines.

dA high simplified pulmonary embolism severity index (sPESI) was defined as the presence of at least one of the following criteria: age >80 years, systolic systemic pressure <100 mmHg, heart rate >110 b.p.m., oxygen saturation <90%, cancer, heart failure, and chronic lung disease.9